110 related articles for article (PubMed ID: 9194388)
1. [A study on antiprothrombin antibodies in antiphospholipid syndrome].
Ieko M; Triplett DA; Kohno M; Ohmoto A; Notoya A; Sawada K; Koike T
Rinsho Ketsueki; 1997 May; 38(5):426-32. PubMed ID: 9194388
[TBL] [Abstract][Full Text] [Related]
2. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
[TBL] [Abstract][Full Text] [Related]
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
4. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
5. The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation.
Sakai Y; Atsumi T; Ieko M; Amengual O; Furukawa S; Furusaki A; Bohgaki M; Kataoka H; Horita T; Yasuda S; Koike T
Arthritis Rheum; 2009 Aug; 60(8):2457-67. PubMed ID: 19644870
[TBL] [Abstract][Full Text] [Related]
6. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
[TBL] [Abstract][Full Text] [Related]
8. Antiprothombin antibodies and the diagnosis of antiphospholipid syndrome.
Amengual O; Atsumi T; Koike T
Clin Immunol; 2004 Aug; 112(2):144-9. PubMed ID: 15240157
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of anti-phosphatidylserine-prothrombin complex antibodies in antiphospholipid syndrome].
Kaburaki J; Kuwana M; Kameda H; Takeuchi T; Okada J; Katayama M; Yoshida S; Ikeda Y
Rinsho Ketsueki; 2005 Jan; 46(1):19-21. PubMed ID: 16708913
[TBL] [Abstract][Full Text] [Related]
10. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
Miesbach W; Matthias T; Scharrer I
Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
12. Antiprothrombin antibodies--are they worth assaying?
Atsumi T; Amengual O; Yasuda S; Koike T
Thromb Res; 2004; 114(5-6):533-8. PubMed ID: 15507288
[TBL] [Abstract][Full Text] [Related]
13. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential markers of antiphospholipid syndrome.
Vlagea A; Gil A; Cuesta MV; Arribas F; Diez J; Lavilla P; Pascual-Salcedo D
Clin Appl Thromb Hemost; 2013 Jun; 19(3):289-96. PubMed ID: 22387581
[TBL] [Abstract][Full Text] [Related]
14. Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome.
Hoxha A; Ruffatti A; Tonello M; Bontadi A; Salvan E; Banzato A; Pengo V; Punzi L
Lupus; 2012 Jun; 21(7):787-9. PubMed ID: 22635234
[TBL] [Abstract][Full Text] [Related]
15. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS
Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of anti-phosphatidylserine-prothrombin complex antibodies in the diagnosis of anti-phospholipid syndrome].
Kaburaki J; Kuwana M; Ikeda Y
Rinsho Ketsueki; 2003 Jan; 44(1):28-30. PubMed ID: 12649835
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
18. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
19. An IgG antiprothrombin antibody enhances prothrombin binding to damaged endothelial cells and shortens plasma coagulation times.
Zhao Y; Rumold R; Zhu M; Zhou D; Ahmed AE; Le DT; Hahn BH; Woods VL; Chen PP
Arthritis Rheum; 1999 Oct; 42(10):2132-8. PubMed ID: 10524684
[TBL] [Abstract][Full Text] [Related]
20. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
Hanly JG; Smith SA
J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
